Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector




















Sort by: Date|Relevance

Tapping Into a Major Blue Sky Helium Opportunity

In a recent Stockhouse Media podcast , we introduced our investor audience to an intriguing mining play in the heart of Canada’s most prolific helium region – Southern Saskatchewan. No longer just the breadbasket of Canada, investors are now waking up to a ...

China dominates worlds supply chains

Cleaner skies owing to covid-19 lockdowns appear to be the silver lining of the global economy crashing to a sudden halt in March. In fact new evidence shows that high-polluting energy sources were on the wane, even before the coronavirus pandemic. According to the I...

A Boomer's Plea

I was born in the 1950s, a decade dominated by thousands of WWII servicemen marrying and starting families in the creation of the largest demographic in history, the "Baby Boom Generation." The 1950s saw Elvis Presley dominate the entertainment industry with ten #1 hits a...

Neovasc Shares Climb 80% Upon FDA Premarket Approval Filing for Refractory Angina Device

Shares of specialty cardiovascular medical device company Neovasc Inc. opened more than 100% higher after the firm reported that it submitted a Premarket Approval application to the FDA for its Neovasc Reducer device for use in the treatment of refractory angina. This...

INmune Bio Targeting Cancer, Alzheimer's and NASH Simultaneously

We are initiating coverage on INmune Bio Inc. (INMB:NASDAQ) . According to the company, INmune is "Reprogramming the Innate Immune System for the Treatment of Diseases." On the surface, this sounds like a fairly standard biotech tagline, but there's a more here than me...

A psychedelic renaissance

Fifty-three years after LSD was banned by the FDA, psychedelic drugs are making a comeback. Only instead of being the pills, mushrooms and acid tabs that helped college students to “turn on, tune in, drop out” Timothy Leary-style, today’...

Nov 17th 2019, Crypto Chartbook – Indicator divergence

Indicator divergence With a vast following of market speculators, we receive a consistent inflow of questions and comments about the market. Traders ask in our our telegram channel, in which we post our trades live, and via e mail as well as in our public appearances, ab...

Global Central Banks Move To Keep The Party Rolling – Part III

This section of our multi-part article regarding current and past central bank actions, we are going to attempt to look at key elements of the past and present to highlight what we believe may turn out to be an incredible “setup” in the global markets. ...

Analysis Shows Aug/Sept Market Top Pattern Should Form

We have been pouring over the data and currently believe our earlier prediction of a July/August 2019 market top should be revised to an Aug/Sept 2019 expected market top pattern. The following research posts we authored recently suggested a top may form in July/Aug 2019 and b...

Vindication…

Precious metals expert Michael Ballanger discusses geopolitical events and movements in the precious metals markets. Hallelujah! It was only a week ago that I was opining that there was nothing ominous in the technical picture for gold and silver that...
1 2